Europe Peripheral Vascular Devices Market

The Europe peripheral vascular devices market is expected to grow from US$ 3,288.55 million in 2021 to US$ 5,035.19 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028

The Europe peripheral vascular devices market is expected to grow from US$ 3,288.55 million in 2021 to US$ 5,035.19 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028. The alarming rise in peripheral artery diseases has been a primary concern across the region. Atherosclerosis, smoking, alcoholism, and obesity are the major factors that increase the risk of developing these diseases. Further, atherosclerosis is a condition in which fatty deposits build up on the inside walls of the arteries, reducing blood flow. Healthy people over the age of 40 have a 50% chance of getting severe atherosclerosis, with the risk increasing as they get older. The disease mostly affects people over the age of 60, yet it goes unnoticed frequently. The increasing prevalence of atherosclerosis is boosting the peripheral vascular devices market substantially. As per the WHO, in 2021, ~1.13 billion people were suffering from hypertension, a leading cause of premature death. Obesity is associated with high blood pressure, dyslipidemia, diabetes or insulin resistance, and higher fibrinogen and C-reactive protein levels, which increase the risk of cardiovascular diseases. Obesity has been associated with a greater risk of high blood pressure. A few significant players are developing and introducing novel products and technologies to compete with existing products in the market, while others are acquiring and partnering with other companies. Thus, the increasing prevalence of hypertension, smoking, alcoholism, and obesity requiring mobility assistance is contributing to the growth of the market across the region.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe peripheral vascular devices market at a notable CAGR during the forecast period.

 Europe Peripheral Vascular Devices Market Revenue and Forecast to 2028 (US$ Million)       

Europe Peripheral Vascular Devices Market Segmentation       

The Europe peripheral vascular devices market is segmented into product, end user, and country. Based on product, the Europe peripheral vascular devices market is segmented into peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. Further, the peripheral vascular stents segment dominated the market in 2021. Based on end user, the Europe peripheral vascular devices market is segmented into hospitals & clinics, ambulatory care centers, specialty clinics, and others. Further, the hospitals & clinics segment dominated the market in 2021. Based on country, the Europe peripheral vascular devices market is segmented into France, Germany, France, the UK, Italy, Spain, and the Rest of Europe. Further, Germany dominated the market in 2021.  

Abbott, B. Braun Melsungen AG, BD, Boston Scientific Corporation, Cardinal Health Inc, Cook Medical LLC, Edwards Lifesciences Corporation, Medtronic, Teleflex Incorporated, and Terumo Corporation are among the leading companies operating in the Europe peripheral vascular devices market.  

Europe Peripheral Vascular Devices Market Strategic Insights

Europe Peripheral Vascular Devices Market Segmentation Analysis

Europe Peripheral Vascular Devices Market Report Highlights

Europe Peripheral Vascular Devices Report Scope

Europe Peripheral Vascular Devices Market Country and Regional Insights